Mainz Biomed to Showcase at the Gynecology Conference in Stuttgart, Germany, Strengthening Connections within the Medical Community
February 27, 2024 08:01 ET
|
Mainz BioMed NV
Mainz Biomed to Showcase at the Gynecology Conference in Stuttgart, Germany, Strengthening Connections within the Medical Community
Mainz Biomed Announces Distribution Partnership with Praxisdienst for ColoAlert®
February 22, 2024 08:01 ET
|
Mainz BioMed NV
Mainz Biomed Announces Distribution Partnership with Praxisdienst for ColoAlert®
Mainz Biomed Establishes Strategic Partnership with TomaLab to Expand Availability of ColoAlert® in Italy
February 21, 2024 08:01 ET
|
Mainz BioMed NV
Mainz Biomed Establishes Strategic Partnership with TomaLab to Expand Availability of ColoAlert® in Italy
Mainz Biomed Establishes Physician-Led Laboratory Expanding Service Offering for Privately Insured Patients in Germany
February 06, 2024 08:01 ET
|
Mainz BioMed NV
MAINZ BIOMED ESTABLISHES PHYSICIAN-LED LABORATORY EXPANDING SERVICE OFFERING FOR PRIVATELY INSURED PATIENTS IN GERMANY
Mainz Biomed and TestDNA Drive CRC Innovation at the 10th Gdańsk Gastroenterology Symposium
January 11, 2024 08:01 ET
|
Mainz BioMed NV
Mainz Biomed and TestDNA Drive CRC Innovation at the 10th Gdańsk Gastroenterology Symposium
Mainz Biomed Provides Year-End Corporate Review 2023
January 09, 2024 08:01 ET
|
Mainz BioMed NV
Mainz Biomed Provides Year-End Corporate Review 2023
Mainz Biomed and Bantleon Partner to Elevate Corporate Health with Second Phase of CRC Screening Program for Employees
December 19, 2023 08:01 ET
|
Mainz BioMed NV
Mainz Biomed and Bantleon Partner to Elevate Corporate Health with Second Phase of CRC Screening Program for Employees
Mainz Biomed Showcases ColoAlert® at Two Prominent Gastroenterology Conferences in Poland
December 12, 2023 08:01 ET
|
Mainz BioMed NV
Mainz Biomed Showcases ColoAlert® at Two Prominent Gastroenterology Conferences in Poland
Mainz Biomed Reports Positive Topline Results from U.S. eAArly DETECT Study Evaluating Novel mRNA Biomarkers
December 05, 2023 09:01 ET
|
Mainz BioMed NV
Mainz Biomed Reports Positive Topline Results from U.S. eAArly DETECT Study Evaluating Novel mRNA Biomarkers
Mainz Biomed’s Presentation at the 35th Annual Piper Sandler Healthcare Conference to be Made Available via Webcast
November 29, 2023 08:01 ET
|
Mainz BioMed NV
Mainz Biomed’s Presentation at the 35th Annual Piper Sandler Healthcare Conference to be Made Available via Webcast